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Abstract   
Background 
Asthma and attention-deficit/hyperactivity disorder (ADHD) are prevalent in childhood and 
may cause functional impairment and stress in families. Previous research supports an 
association between asthma and ADHD in children, but several aspects of this relationship are 
unclear. 
Objective 
Our aim was to study if the association between asthma and ADHD is restricted to either the 
inattentive or the hyperactive/impulsive symptoms of ADHD, to explore the impact of asthma 
severity and asthma medication and the contribution of shared genetic and environmental risk 
factors on the asthma-ADHD relationship. 
Methods 
Data on asthma, ADHD, zygosity, and possible confounders were collected from parental 
questionnaires at 9 or 12 years on 20 072 twins	through the Swedish Twin Register, linked to 
the Swedish Medical Birth Register, the National Patient Register and the Prescribed Drug 
Register. The association between asthma and ADHD, the impact of asthma severity and 
medication, was assessed by generalized estimating equations.  Cross-twin-cross-trait 
correlations (CTCT) were estimated to explore the relative importance of genes and 
environment for the association.  
Results  
Asthmatic children had a higher risk of also having  ADHD (odds ratio [OR] 1.53, 95% 
confidence interval [CI]: 1.16–2.02). The association was not restricted to either of the two 
dimensions of ADHD. The magnitude of the association  increased with asthma severity (OR 
2.84, 95% CI: 1.86–4.35) for >4 asthma attacks in the last 12 months and was not affected by 
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asthma treatment.  The CTCTs possibly indicate that the genetic component in overlap of the 
disorders is weak.  
Conclusions and Clinical Relevance 
Childhood asthma, especially severe asthma, is associated with ADHD. Asthma medication 
seems not to increase the risk of ADHD. Clinicians should be aware of the potential of ADHD 
in asthma. Optimal asthma care needs to be integrated with effective evaluation and treatment 
of ADHD in children with co-existing disorders. 
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Introduction 
Asthma and attention-deficit/hyperactivity disorder (ADHD) [1] are prevalent chronic health 
conditions in childhood which may cause functional impairment and stress in families [2, 3]. 
There is evidence from some cross-sectional studies to suggest an association between asthma 
and ADHD [4-7], while other studies did not find a relationship [8, 9].  Several aspects of this 
relationship are still poorly understood [8, 10]. 
There are several potential explanations to the observed overlap between asthma and ADHD. 
Asthma may contribute to the subsequent	development of ADHD, and a dose-response 
relationship between asthma severity and rates of behavioural	problems has been suggested 
[11]. In a longitudinal study of 1480 Swedish twin pairs our group recently found that 
childhood asthma was associated with a linear increase in risk of hyperactivity–impulsivity 
behaviours later in adolescence [12]. Asthma severity and medication are however tightly 
linked, and it is possible that medication rather than asthma is the explanation for the 
association. Treatment with β2-agonists	and inhaled corticosteroids (ICS) have been reported 
to cause behavioural side effects [13, 14 ]. However, we did not find any significant 
difference in hyperactivity–impulsivity between asthmatic children with or without asthma 
medication [12]. 
Alternatively, asthma and ADHD may be indirectly linked via shared genetic and/or 
environmental risk factors. Several environmental risk factors such as low parental 
socioeconomic status and parental smoking have been associated with both asthma and 
ADHD [15-18]. Although it has been proposed that there is a common environmental 
mechanism underlying the development of asthma and/or ADHD [19], the association seems 
to remain in other studies after adjustment for these potential confounders [11, 12].  
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Twin studies have demonstrated that both asthma and ADHD are highly heritable [20, 21]. 
However,  the few previous family and twin studies have produced conflicting results 
regarding the genetic and shared environmental contribution to the overlap between asthma 
and ADHD. Two previous family studies did not find any genetic and/or shared 
environmental component underlying the association [8, 9], whereas our recent twin study 
reported that the overlap between asthma and hyperactivity–impulsivity was largely due to 
genetic influences [12]. Clearly, additional research in larger populations is needed to clarify 
the impact of environmental and genetic factors on the link between asthma–ADHD. 
 
The aim of this study was to i) confirm the association of asthma and ADHD symptoms in 
childhood and to explore if the association was restricted to the inattentive or the 
hyperactive/impulsive symptoms of ADHD, ii) investigate the impact of asthma severity and 
asthma medication (inhaled β2-agonists and/or inhaled corticosteroids) on the asthma-ADHD 
relationship and iii) examine the contribution of shared genetic and environmental risk factors 
to the overlap between the two conditions. We used a large cross-sectional twin cohort based 
on the population-based Swedish Twin Register with data on asthma and ADHD-symptoms 
as well as asthma medication and specialist care diagnoses from the Swedish National Health 
Registers. 
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Methods  
Study design and population 
 
This population-based cross-sectional study used data from the Child and Adolescent Twin 
Study in Sweden (CATSS) [22] and three Swedish national registers held by the Swedish 
National Board of Health and Welfare. CATSS collects information on 9-year-old (born since 
July 1995) or 12-year-old (born July 1992–June 1995) twins through parental interviews [22]. 
The population used in this study included all children born between 1992 and 2002 whose 
parents were contacted for interviews between Aug 2003 and Aug 2011 (n=27 260).  Twins 
were excluded if they were living abroad, had a parent not fluent in Swedish, or they or their 
parent were disabled (n=860). In total, 26 400 twins were eligible and 20 302 (75%) 
completed the interview. The final study population (n=20 072) was restricted to twins with 
complete answers to the main questions on asthma and ADHD.  
 
Data from CATSS was linked to the Medical Birth Register (MBR), National Patient Register 
(NPR) and Prescribed Drug Register (PDR) using the Personal Identification Number (PIN), a 
unique identifier for each resident. Further details regarding data collection and linkage to 
these national registers are described elsewhere [17, 18, 23-25] .The MBR contains maternal 
and child characteristics data on more than 99% of all births in Sweden since 1973. The NPR 
covers all inpatient diagnoses since 1987 and about 80% of all outpatient diagnoses since 
2001, recorded with International Classification of Disease (ICD)-9 and ICD-10 codes. The 
PDR encompasses data on all prescribed drugs dispensed in Swedish pharmacies since July 1, 
2005 [26], coded by the Anatomical Therapeutic Chemical (ATC) system.  Register data was 
available for twins born 1992–2001 (94% of the study population).  Data from NPR and PDR 
was collected until Dec 31, 2009.  
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Measures 
Asthma  
The main definition of asthma, “asthma reported by questionnaire”, and a secondary variable 
“doctor's asthma diagnosis reported by questionnaire”,  were derived from the International 
Study of Asthma and Allergies in Childhood (ISAAC) questions in CATSS [18, 27]. Asthma 
cases were also identified from the NPR “asthma diagnosis based in register”, if a record in 
the NPR with asthma as the primary or a secondary diagnosis (ICD-9 code 493 or ICD-10 
codes J45 and J46) was recorded at least once. The quality of doctor-diagnosed asthma in the 
NPR is considered high [24]. Finally, a fourth asthma variable “any asthma” was derived 
from “asthma reported by questionnaire” and “asthma diagnosis based in register”. 		
 
Asthma severity 
Parents were also asked ISAAC questions about wheezing. If they reported either asthma or 
wheezing, they were asked follow-up questions on number of attacks in the last 12 months 
[27].  Answers  were categorised into five levels:	No; Yes, previous asthma only; Yes, current 
asthma but no attacks in the last 12 months; 1-3 attacks in the last 12 months, and >	4 attacks 
in the last 12 months.	
 
Asthma medication 
Dispensed asthma medications β2-agonists (R03AC), inhaled corticosteroids (ICS) including 
those combined with long-acting β2-agonists (R03BA, R03AK) and leukotriene receptor 
antagonists (R03DC) were retrieved from the PDR up until the date of interview, for the 
subset of individuals with any asthma and at least 18 months between start of the PDR and the 
interview (i.e. individuals with interviews later than Dec 31, 2006). In our analyses, asthma 
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medication was categorised in three ways: (1) dispensed any asthma drugs or (2) dispensed 
inhaled β2-agonists and/or ICS at least once or (3) dispensed inhaled β2-agonists and/or ICS at 
least three times.  
 
ADHD 
The CATSS interviews included an ADHD scale as part of the Autism – Tics, ADHD, and 
other Comorbidities inventory (A-TAC). This screening instrument asks symptom questions 
based on the DSM-IV criteria including two modules:  Attention and Hyperactivity. Response 
options for each question are coded as “0 – no”, “0.5 – yes, to some extent” and “1 – yes”. 
The A-TAC ADHD scale or subscales can be used to identify possibly impairing ADHD 
symptoms.  A score of 6 or more is used as a ”screening” ADHD diagnosis, and a score of 
12.5 or more selects children with ADHD at a level of clinical concern (“research” ADHD 
diagnosis) [28].  
In this study, the ADHD outcome variable was defined as parental report of either  a 
screening or research-level ADHD diagnosis. The two modules Attention and Hyperactivity 
(with cut-off score > 6 on each scale) in A-TAC were also analysed separately. Finally, we 
defined “register-based ADHD diagnosis” as either an ADHD diagnosis in NPR 
(Hyperkinetic syndrome, ICD-9 code 314; or Hyperkinetic disorders, ICD-10 code: F900 
registered, and/or dispensed ADHD-drugs in PDR: centralstimulants (N06BA01, N06BA04) 
or atomoxetin (N06BA09) registered at least once.  
 
Covariates  
Atopic eczema was denoted if parents reported “atopic eczema” or “flexural eczema” 
according to the ISAAC question in CATSS [29] . Information on a child's sex and zygosity 
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[30] as well as data on the mother's birth country and level of education (<9 years, 10–12 
years or graduate education) and parental cohabitation at time of interview (yes/no) was 
collected in the CATSS interview. Data on birth weight and gestational age (GA) and 
maternal smoking habits at the first antenatal care visit (0, 1–9 or >10 cigarettes per day) and 
age at delivery were retrieved from MBR. 
 
Statistical analysis 
The associations between asthma and ADHD were analysed using the different ADHD 
diagnoses (screening, research, or register-based) as dichotomous outcome variables, and the 
different asthma measures as independent variables, one by one.  We used generalized 
estimating equations with the logit link and exchangeable covariance structure to address the 
correlation caused by the clustering of observations within twin pairs [31]. Odds ratios and 
95% confidence intervals (CI) were first adjusted for the child's sex and age.  Secondly, 
models were adjusted for the child's sex, age, birth weight, GA;  as well as the maternal 
characteristics age at delivery, smoking,  birth country,  education, and parental cohabitation.  
Thirdly, models were adjusted for all the previous covariates and additionally for atopic 
eczema. Furthermore we tested sex differences in the associations between asthma and 
ADHD by including an interaction term, and if statistically significant we estimated separate 
ORs for males and females. The classical twin design was used to explore the relative impact 
of genetic, shared environmental and non-shared environmental factors for asthma, ADHD 
and the overlap between the disorders. Briefly, tetrachoric twin correlations for asthma and 
ADHD were estimated separately for monozygotic (MZ) and dizygotic (DZ) twin pairs. The 
corresponding cross-twin cross-trait correlations (i.e. correlation between asthma status in one 
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twin and ADHD status in the co-twin) were estimated to assess the relative importance of 
genetic and environmental influences for the overlap between asthma and ADHD. 
All statistical analyses were carried out using the SAS software package version 9.2 and the 
significance level was 0.05. 
 
Permission for the study was obtained from the Regional Ethical Review board in Stockholm, 
Sweden. 
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Results  
The proportion of study subjects with parent reported asthma and screening ADHD diagnosis  
by child and maternal characteristics is presented in Supplementary Table S1. The overall 
cumulative incidence of asthma was 14.0%,  and 9.9% of the study population had a 
screening diagnosis of ADHD. Two percent had both disorders at 9 or 12 years of age. The 
cumulative incidence of research ADHD diagnosis in the study population was 1.9% 
(375/20,072) and 2.0% (383/18,931) had a register-based diagnosis of ADHD. About 76% of 
the children with a register-based ADHD diagnosis also had a parent-reported screening 
ADHD diagnosis in the A-TAC interviews.  
 
Table 1 presents the associations between asthma and the ADHD outcomes. After adjusting 
for sex, children with asthma were more likely to have ADHD than children with no asthma. 
Children with parent-reported asthma in questionnaires	had an increased odds of a screening 
diagnosis of ADHD (fully adjusted OR 1.32, 95% CI: 1.14–1.52), a research diagnosis of 
ADHD (OR 1.86, 95% CI: 1.39–2.49) and a register-based ADHD diagnosis (OR 1.55, 95% 
CI: 1.16–2.07). The table displays similar findings for the association between doctors' 
diagnosis of asthma reported by questionnaires and in registers, or with any asthma, and the 
various ADHD outcomes . There were no sex differences in the association between asthma 
and ADHD, except that a research diagnosis of ADHD was more strongly associated  with a 
doctor’s diagnosis of asthma in females (p for interaction=0.044; OR 2.88, 95% CI: 1.69–4.89 
in females; OR 1.48, 95% CI: 1.02–2.13 in males).		
Asthma was associated equally with Attention and Hyperactivity.  Using the Attention and 
Hyperactivity subscales of ADHD separately as outcome variables, we obtained similar 
adjusted ORs for the association with asthma: parental report of at least six inattentive 
symptoms: OR 1.56, 95% CI: 1.24–1.97 and parental report of at least six hyperactivity–
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impulsivity symptoms: OR 1.59, 95% CI: 1.21–2.10. The association between asthma and 
ADHD did not change with adjustment for eczema (data not shown). 
 
Table 2 displays the relation between the parent-reported frequency of asthma attacks in the 
last 12 months and the odds of ADHD. After adjusting for all potential confounders, the OR 
for the association with the screening ADHD diagnosis consistently increased with an 
increasing number of asthma attacks compared to no asthma (1-3 attacks: OR 1.40, 95% CI: 
1.08–1.83 and  >4 attacks: OR 1.55, 95% CI: 1.17–2.04. The association was also statistically 
significant for the “yes, previous asthma only” category of asthma attacks (OR 1.29, CI 95%: 
1.04–1.60). Similar results were obtained for the association between asthma attacks in the 
last 12 months and research diagnosis of ADHD, but were only significant for >4 attacks (OR 
2.84, 95% CI: 1.86–4.35) and “yes, previous asthma only” (OR 1.87, 95% CI: 1.23–2.84). 
Furthermore, there was a similar significant association between a register-based ADHD 
diagnosis in all categories of asthma attacks in the last 12 months except the 1-3 attacks 
category (data not shown).  
 
Table 3 illustrates the association between different classes of dispensed asthma medications 
and the risk of ADHD. Both asthma groups, that is with and without dispensed asthma drugs, 
had increased odds of a screening or research diagnosis of ADHD, but there was no 
significant difference between the groups (screening diagnosis of ADHD: OR 1.36, 95% CI: 
1.03–1.80 for asthma, but no dispensed drugs;	OR 1.56, 95% CI: 1.21–2.01 for asthma with  
any dispensed asthma medication in the fully adjusted model). A higher number of dispensed 
drugs did not increase the odds of a screening diagnosis of ADHD: OR 1.46, 95% CI: 1.16–
1.84 for no dispensed drugs;	OR 1.55, 95% CI: 1.08–2.22 for dispensed both inhaled β2-
agonists and ICS > 3 times in the fully adjusted model). For a research diagnosis of ADHD, 
Kirsten   2015-3-18 13:29
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the OR for having dispensed both inhaled β2-agonists and ICS > 3 times (OR 2.69, 95% CI: 
1.57–4.62) was slightly higher than for children with asthma but without dispensed drugs (OR 
2.06, 95% CI: 1.39–3.07).   
 
Table 4 shows the results of the twin analyses. These include intra-class and cross-trait cross-
twin correlations (CTCT; the correlation between one twin's status on asthma and the co-
twin's status on a screening or research ADHD diagnosis), correlations for parent-reported 
asthma and the two ADHD diagnoses, by zygosity. MZ intra-class correlations were 
consistently higher than the corresponding DZ correlations [parent-reported asthma: MZ (OR 
0.87, 95% CI: 0.85–0.90) and DZ same sex  (OR 0.43, 95% CI: 0.36–0.49); research ADHD 
diagnosis: MZ (OR 0.85, 95% CI: 0.77–0.93) and DZ same sex (OR 0.37, 95% CI: 0.20–
0.54)], These results support genetic influences on asthma and on ADHD in both sexes. 
However, the CTCT correlations for MZ twins and DZ twins were similar in strength, or even 
higher among DZ twins [asthma and research ADHD diagnosis: MZ 0.05 (-0.08, 0.17 ) vs DZ 
same sex  0.13 (0.03, 0.23)] , possibly suggesting that any genetic component in the overlap in 
the liability of the phenotypes is weak. 
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Discussion 
In this cohort analysis of 20,072 Swedish twins aged 9 or 12 we found that children with 
asthma had an almost twofold increased risk of ADHD compared with those without asthma. 
The association was not restricted to the inattentive or the hyperactive/impulsive symptoms of 
ADHD. The magnitude of the association increased with asthma severity defined as frequency 
of asthma attacks, but was not affected by asthma treatment. The results were robust after 
adjusting for potential confounders including atopic eczema [32] and independent of whether 
asthma or ADHD was defined as parent-reported symptoms on a questionnaire or as a 
register-based diagnosis. To our knowledge, the effect of asthma severity and asthma drug 
treatment on associated ADHD symptoms in childhood has not been studied previously. The 
study design is novel, and combines parent reported symptoms with national registers in a 
large population of twins. Furthermore, this is the largest population-based twin- and register-
based study on childhood asthma and ADHD to date, and supports the hypothesis that asthma 
is associated with ADHD.  However, due to the cross-sectional study design, we could not 
determine the causal direction in the association between asthma and ADHD. 
 
Previous large epidemiological studies have shown a cross-sectional association between 
asthma and ADHD [4, 6, 33, 34] in contrast to studies with small sample sizes (N~1,000) [8, 
9]. Recent analyses from  nationwide population-based studies with diagnosis based on 
parental report [6], register-based diagnoses [34] or prescription data [33] reported similar 
ORs for the association between asthma and ADHD as we found in our study. In a previous 
study we distinguished between the two DSM-IV ADHD symptom dimensions and reported 
that childhood asthma predicts hyperactivity–impulsivity, but not inattention, in adolescence 
[12]. In the present study, we found that the ORs for the association between asthma and 
ADHD were similar regardless of defining ADHD symptoms as hyperactivity–impulsivity or 
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inattention, or the combination of those. This divergent result may depend on the difference in 
study designs or age. In the present cross-sectional study information on asthma and ADHD 
were collected at the same age (9 or 12 years). In contrast, the previous study was longitudinal 
between 7 to 14 years of age. Although recent studies have shown a relationship between 
atopic eczema and ADHD [32], our results did not change when adjusting for eczema which 
is in line with our previous study [12]. 
 
The prevalence of research ADHD diagnosis was rather low and in line with the prevalence of 
register-diagnosed ADHD, indicating that this group consisted of children with severe ADHD 
in need of health care. Another explanation is that parents of children with high A-TAC 
scores might tend to underreport or not participate in the study. 
 
Current asthma severity was linearly associated with ADHD which confirms results from 
previous studies [10-12]. ADHD causes psychological distress and may exacerbate the 
severity of asthma [11, 35]. On the other hand, childhood asthma, especially severe disease, 
may be associated with family distress and behavioural problems and interpreted as ADHD or 
worsen functional impairment caused by ADHD [2, 16, 35]. The stress of treating severe 
asthma may also have psychological impact on children and family relationships.  In addition, 
we found an increased prevalence of ADHD in children who only had reported a history of 
previous asthma. The explanation may be that asthma at a young age influences the risk of 
developing ADHD symptoms by school-age. This result is in line with our longitudinal study 
of asthma and ADHD, indicating that the correct causal pathway is that asthma precedes 
ADHD [12]. Although the present study is cross-sectional, there may be other explanations 
for the overlap. Gene expression resulting in immune system dysfunction may be a common 
pathophysiological mechanism underlying both disorders [36]. 
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We found no evidence to support the notion that the association between asthma and ADHD 
was modified by asthma medication.	  Even children who had dispensed both inhaled β2-
agonists and ICS > 3 times had similar odds of screening ADHD diagnosis as those without 
dispensed medication. This may be due to severe asthma in spite of intensive medication or 
severe cases being undertreated. Possibly the ADHD symptoms are being ignored, or 
misinterpreted as asthma or as side-effects caused by asthma medication. Another possibility 
is that the restlessness caused by β2-agonist may be a transient effect [37]. Our findings of no 
significant effects by medication on the association based on information from the PDR 
replicate the result from our previous longitudinal study of Swedish twins where use of 
inhaled β2-agonists and/or ICS was assessed from parental questionnaires [12]. 
 
The association between asthma and ADHD was stable when controlled for child and 
maternal characteristics, including sex, birth weight, maternal level of education and smoking 
habits. Previous research has not adjusted for all these covariates [11, 34, 38]. Results from 
the twin analyses confirm previous research suggesting a strong genetic component for 
asthma and ADHD in both sexes [11, 20, 21]. However, the estimated cross-twin cross-trait 
correlations were similar in MZ and DZ twins, or even higher in DZ twins. This contradicts 
the notion of a genetic component in the co-occurence of asthma and ADHD. Consequently, 
we could not fit a model for estimating the size of such a genetic component. 
 
There are several strengths of our study. Firstly, we studied a large population. Secondly, we 
obtained robust results independent of whether validated questionnaire or register-based 
variables on asthma and ADHD were used [24, 28], and we investigated the two subscale 
measures of ADHD – Attention or Hyperactivity – separately. Thirdly, we adjusted for 
several socioeconomic confounders which have been limited in previous studies [10, 34]. 
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Fourthly, we were able to evaluate the severity of both asthma and ADHD symptoms in 
contrast to a recent study which was register-based only [34].  
 
This study should be interpreted in the context of its limitations. Firstly, the study is cross-
sectional, which constrains possibilities to study the direction of effect between asthma and 
ADHD. Secondly, we have no external validation of parent-reported hyperactivity or 
inattention, such as teacher reports. Teachers tend to report more ADHD symptoms both in 
children with or without asthma than parents do [2, 39]. However, there were no substantial 
differences between the results in the parent-reported ADHD groups of screening- or 
research-based diagnoses of ADHD and the group with the register-based clinical diagnosis of 
ADHD, which usually includes assessment of impairment in school [1]. Thirdly, asthma 
severity was based on number of asthma attacks in the last 12 months. We did not have 
additional ways to assess severity such as children's lung function or other clinical data. 
Fourthly, we have no access to detailed clinical information on treatment with asthma drugs, 
doses or duration, or treatment compliance. Finally, we did not control for comorbid 
psychiatric disorders, [38] or sleeping problems which have been reported to increase the risk 
of ADHD symptoms [40]. Generalizability of our findings in twins to the general population 
may be a concern, although previous studies indicate that twins do not differ from singletons 
concerning their risk of asthma [41] or ADHD [42]. Moreover, our estimated ORs for the 
association between asthma and ADHD are of similar magnitude as those found in studies in 
non-twin populations [6, 33, 34], suggesting a similar etiology in twins and singletons.  
 
In conclusion, this large population-based cross-sectional study indicates that asthma and 
asthma severity but not asthma medication is associated with ADHD symptoms in childhood. 
These findings highlight the need for optimal clinical care of children with asthma  to be  
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integrated with effective management strategies for ADHD symptoms [34]. Clinicians need to 
be aware of the potential for ADHD especially in children with severe asthma and optimize 
drug treatment also for children with both conditions.	Our results indicate that it would be 
valuable to further elucidate the relationship between parental perception of child's behaviour 
and illness to establish services for early identification and intervention for behavioural 
difficulties in children with asthma – or asthma intervention for children with ADHD – to 
minimize the impact of physical illness and psychological disturbance [2, 10].  
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